Jing Qin
Author
Alternate names Jing. Qin, J. Qin
Past institutions National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Institutes of Health, Hainan Maternal and Child Health Hospital, Guangdong University Of Finances and Economics +5 more
ORCID: Yes
H-index: 56
I10-index: 140
Works count: 319
Citations count: 10,580
A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model
2001 · Craig H. Moskowitz, Stephen D. Nimer, et al. · Blood
Prevalence of kidney stones in China: an ultrasonography based cross‐sectional study
2017 · Guohua Zeng, Zanlin Mai, et al. · BJU International
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
2004 · Tarun Kewalramani, Andrew D. Zelenetz, et al. · Blood